FI970424A0 - Imidatsolin uusi käyttö ja uusia johdannaisia, menetelmä niiden valmistamiseksi, näin saatuja uusia välituotteita, niiden uusia lääketieteellisiä käyttösovelluksia ja niitä sisältäviä farmaseuttisia koostumuksia - Google Patents
Imidatsolin uusi käyttö ja uusia johdannaisia, menetelmä niiden valmistamiseksi, näin saatuja uusia välituotteita, niiden uusia lääketieteellisiä käyttösovelluksia ja niitä sisältäviä farmaseuttisia koostumuksiaInfo
- Publication number
- FI970424A0 FI970424A0 FI970424A FI970424A FI970424A0 FI 970424 A0 FI970424 A0 FI 970424A0 FI 970424 A FI970424 A FI 970424A FI 970424 A FI970424 A FI 970424A FI 970424 A0 FI970424 A0 FI 970424A0
- Authority
- FI
- Finland
- Prior art keywords
- new
- pct
- alkenyl
- imidazole
- alkyl
- Prior art date
Links
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 title 3
- 239000000543 intermediate Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000304 alkynyl group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- -1 carboxy, nitro, cyano, amino, carbamoyl Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
- 125000003396 thiol group Chemical class [H]S* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9409566A FR2723370B1 (fr) | 1994-08-02 | 1994-08-02 | Nouveaux derives de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
| PCT/FR1995/001034 WO1996004276A1 (fr) | 1994-08-02 | 1995-08-01 | Nouvelle utilisation et nouveaux derives de l'imidazole, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI970424A0 true FI970424A0 (fi) | 1997-01-31 |
| FI970424A FI970424A (fi) | 1997-04-01 |
Family
ID=9465986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI970424A FI970424A (fi) | 1994-08-02 | 1997-01-31 | Imidatsolin uusi käyttö ja uusia johdannaisia, menetelmä niiden valmistamiseksi, näin saatuja uusia välituotteita, niiden uusia lääketieteellisiä käyttösovelluksia ja niitä sisältäviä farmaseuttisia koostumuksia |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5811444A (fi) |
| EP (1) | EP0776325B1 (fi) |
| JP (1) | JP4044134B2 (fi) |
| CN (1) | CN1082961C (fi) |
| AT (1) | ATE228127T1 (fi) |
| AU (1) | AU707927B2 (fi) |
| BR (1) | BR9508481A (fi) |
| CA (1) | CA2196218A1 (fi) |
| DE (1) | DE69528902T2 (fi) |
| DK (1) | DK0776325T3 (fi) |
| ES (1) | ES2182909T3 (fi) |
| FI (1) | FI970424A (fi) |
| FR (1) | FR2723370B1 (fi) |
| HU (1) | HU221464B (fi) |
| IL (1) | IL114753A0 (fi) |
| MX (1) | MX9700821A (fi) |
| PT (1) | PT776325E (fi) |
| RU (1) | RU2187507C2 (fi) |
| WO (1) | WO1996004276A1 (fi) |
| ZA (1) | ZA956453B (fi) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2740773B1 (fr) * | 1995-11-08 | 1997-12-19 | Roussel Uclaf | Nouveaux derives de l'imidazole, procede de preparation, intermediaires obtenus, application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| FR2740774B1 (fr) * | 1995-11-08 | 1997-12-19 | Roussel Uclaf | Nouveaux derives d'imidazole n-benzyldioxole, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation |
| FR2831822A1 (fr) * | 2001-11-07 | 2003-05-09 | Inst Nat Sante Rech Med | Utilisation therapeutique de derives 4-mercapto- ou 4-seleno-imidazoles |
| WO2013123349A1 (en) * | 2012-02-16 | 2013-08-22 | Dow Agrosciences Llc | Methods of producing sulfilimine compounds |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0003732B1 (en) * | 1978-02-01 | 1983-10-19 | The Wellcome Foundation Limited | Imidazole derivatives and salts thereof, their synthesis, and pharmaceutical formulations thereof |
| US5559105A (en) * | 1992-07-17 | 1996-09-24 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
| EP0650484B1 (en) * | 1992-07-17 | 2000-01-26 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
-
1994
- 1994-08-02 FR FR9409566A patent/FR2723370B1/fr not_active Expired - Fee Related
-
1995
- 1995-07-27 IL IL11475395A patent/IL114753A0/xx unknown
- 1995-08-01 BR BR9508481A patent/BR9508481A/pt not_active Application Discontinuation
- 1995-08-01 MX MX9700821A patent/MX9700821A/es unknown
- 1995-08-01 CN CN95195205A patent/CN1082961C/zh not_active Expired - Fee Related
- 1995-08-01 AU AU31179/95A patent/AU707927B2/en not_active Ceased
- 1995-08-01 CA CA002196218A patent/CA2196218A1/fr not_active Abandoned
- 1995-08-01 DK DK95927004T patent/DK0776325T3/da active
- 1995-08-01 PT PT95927004T patent/PT776325E/pt unknown
- 1995-08-01 US US08/776,953 patent/US5811444A/en not_active Expired - Fee Related
- 1995-08-01 RU RU97103193/04A patent/RU2187507C2/ru not_active IP Right Cessation
- 1995-08-01 WO PCT/FR1995/001034 patent/WO1996004276A1/fr active IP Right Grant
- 1995-08-01 ES ES95927004T patent/ES2182909T3/es not_active Expired - Lifetime
- 1995-08-01 AT AT95927004T patent/ATE228127T1/de not_active IP Right Cessation
- 1995-08-01 EP EP95927004A patent/EP0776325B1/fr not_active Expired - Lifetime
- 1995-08-01 JP JP50626196A patent/JP4044134B2/ja not_active Expired - Fee Related
- 1995-08-01 HU HU9700295A patent/HU221464B/hu not_active IP Right Cessation
- 1995-08-01 DE DE69528902T patent/DE69528902T2/de not_active Expired - Fee Related
- 1995-08-02 ZA ZA956453A patent/ZA956453B/xx unknown
-
1997
- 1997-01-31 FI FI970424A patent/FI970424A/fi unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2196218A1 (fr) | 1996-02-15 |
| EP0776325B1 (fr) | 2002-11-20 |
| RU2187507C2 (ru) | 2002-08-20 |
| ATE228127T1 (de) | 2002-12-15 |
| FI970424A (fi) | 1997-04-01 |
| FR2723370A1 (fr) | 1996-02-09 |
| WO1996004276A1 (fr) | 1996-02-15 |
| US5811444A (en) | 1998-09-22 |
| BR9508481A (pt) | 1997-09-30 |
| FR2723370B1 (fr) | 1996-09-13 |
| ZA956453B (en) | 1996-08-05 |
| DK0776325T3 (da) | 2003-03-17 |
| MX9700821A (es) | 1997-05-31 |
| DE69528902T2 (de) | 2003-04-10 |
| CN1082961C (zh) | 2002-04-17 |
| EP0776325A1 (fr) | 1997-06-04 |
| HUT77767A (hu) | 1998-08-28 |
| CN1158613A (zh) | 1997-09-03 |
| IL114753A0 (en) | 1995-11-27 |
| JP4044134B2 (ja) | 2008-02-06 |
| AU3117995A (en) | 1996-03-04 |
| JPH10504544A (ja) | 1998-05-06 |
| AU707927B2 (en) | 1999-07-22 |
| DE69528902D1 (de) | 2003-01-02 |
| HU221464B (en) | 2002-10-28 |
| ES2182909T3 (es) | 2003-03-16 |
| PT776325E (pt) | 2003-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE148108T1 (de) | Beta,beta-dimethyl-4-piperidinethanamin-derivat als inhibitoren der cholesterin-biosynthese | |
| ZA9610418B (en) | Phenylimidazolidines containing in particular a nitrooxy or carbonyloxy radical, preparation process and intermediates, use as medicaments, new uses and pharmaceutical compositions. | |
| ZA955105B (en) | Thiazolidine derivatives their preparation and compositions containing them | |
| ATE204471T1 (de) | Pyrimidin- oder triazincarbonsäurederivate zur verwendung als arzneimittel | |
| FI964482A (fi) | Amidijohdannaisia ja niiden käyttö lääkkeenä | |
| FI970424A0 (fi) | Imidatsolin uusi käyttö ja uusia johdannaisia, menetelmä niiden valmistamiseksi, näin saatuja uusia välituotteita, niiden uusia lääketieteellisiä käyttösovelluksia ja niitä sisältäviä farmaseuttisia koostumuksia | |
| ATE212996T1 (de) | Anthracyclin-derivate | |
| FI970423A0 (fi) | Uusia imidatsolijohdannaisia, menetelmä niiden valmistamiseksi, näin saatuja uusia välituotteita, niiden lääketieteellisiä käyttösovellutuksia ja niitä sisältäviä farmaseuttisia koostumuksia | |
| ATE273979T1 (de) | Xanthinderivate, zwischenprodukte und verwendung zur behandlung von osteoporosis | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto | |
| ZA955052B (en) | Pyrrolidine derivatives their preparation and compositions containing them | |
| DE59309898D1 (de) | 4-oxo-azetidin-2-sulfonsäureamide und ihre salze, verfahren zu deren herstellung und ihre verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: HOECHST MARION ROUSSEL |